meropenem 500 mg powder for solution for injection/infusion
as kalceks - meropenem trihydrate - powder for solution for injection/infusion - meropenem
meropenem 500 mg powder for solution for injection/infusion
steriscience b.v. - meropenem trihydrate - powder for solution for injection/infusion - meropenem
meropenem 1 g powder for solution for injection or infusion
rowex ltd - meropenem trihydrate - powder for solution for injection/infusion - meropenem
meropenem 500 mg powder for solution for injection or infusion
rowex ltd - meropenem trihydrate - powder for solution for injection/infusion - meropenem
meropenem injection powder for solution
par pharmaceutical, inc. - meropenem (unii: fv9j3ju8b1) (meropenem anhydrous - unii:yop6px0bao) - meropenem 500 mg in 20 ml
meropenem 500 mg powder for solution for injection or infusion
fresenius kabi deutschland gmbh - meropenem trihydrate - powder for solution for injection/infusion - 500 milligram(s) - carbapenems; meropenem
meropenem 1 g powder for solution for injection or infusion
fresenius kabi deutschland gmbh - meropenem trihydrate - powder for solution for injection/infusion - 1 gram(s) - carbapenems; meropenem
meropenem injection powder for solution
cardinal health - meropenem (unii: fv9j3ju8b1) (meropenem anhydrous - unii:yop6px0bao) - meropenem 500 mg in 10 ml
meropenem injection, powder, for solution
hospira, inc. - meropenem (unii: fv9j3ju8b1) (meropenem anhydrous - unii:yop6px0bao) - meropenem for injection, usp (i.v.) is indicated for the treatment of complicated skin and skin structure infections (csssi) due to staphylococcus aureus (methicillin-susceptible isolates only), streptococcus pyogenes, streptococcus agalactiae, viridans group streptococci, enterococcus faecalis (vancomycin-susceptible isolates only), pseudomonas aeruginosa, escherichia coli, proteus mirabilis, bacteroides fragilis, and peptostreptococcus species. meropenem for injection, usp (i.v.) is indicated for the treatment of complicated appendicitis and peritonitis caused by viridans group streptococci, escherichia coli , klebsiella pneumoniae , pseudomonas aeruginosa , bacteroides fragilis , b. thetaiotaomicron , and peptostreptococcus species. meropenem for injection, usp (i.v.) is indicated for the treatment of bacterial meningitis caused by haemophilus influenzae , neisseria meningitidis and penicillin-susceptible isolates of streptococcus pneumoniae . meropenem for injection, usp (i.v.) has been found to be
meropenem injection, powder, for solution
wg critical care, llc - meropenem (unii: fv9j3ju8b1) (meropenem anhydrous - unii:yop6px0bao) - meropenem for injection, usp is indicated for the treatment of complicated skin and skin structure infections (csssi) due to staphylococcus aureus (methicillin-susceptible isolates only), streptococcus pyogenes, streptococcus agalactiae, viridans group streptococci, enterococcus faecalis (vancomycin-susceptible isolates only), pseudomonas aeruginosa, escherichia coli, proteus mirabilis, bacteroides fragilis, and peptostreptococcus species. meropenem for injection, usp is indicated for the treatment of complicated appendicitis and peritonitis caused by viridans group streptococci, escherichia coli , klebsiella pneumoniae , pseudomonas aeruginosa , bacteroides fragilis , b. thetaiotaomicron , and peptostreptococcus species. meropenem for injection, usp is indicated for the treatment of bacterial meningitis caused by haemophilus influenzae , neisseria meningitidis and penicillin-susceptible isolates of streptococcus pneumoniae . meropenem for injection, usp has been found to be effective in eliminating con